EUCTR2012-004954-27-GB进行中(未招募)不适用
A single centre open-label randomised controlled trial of long term pituitary down-regulation before in vitro fertilisation for women with endometriosis: a pilot study - Pituitary down-regulation before IVF for women with endometriosis
Clinical Trials and Research Governance, University of Oxford0 个研究点目标入组 100 人开始时间: 2012年11月30日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Participant is willing and able to give informed consent for participation in the study. • Female aged 18 to 39 years old. • Intending to undergo treatment with a first, second or third cycle of IVF or IVF-ICSI. • Diagnosed with any degree of endometriosis. • Participants must meet World Health Organisation Group 1 or 2 eligibility requirements for Combined Oral Contraceptive use.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 100
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range 0
排除标准
- •The participant does not understand the English language, or has special communication needs. This is because it is impractical to provide, for this small scale study, information sheets and consent forms in other languages except English. • The patient has already undergone 3 or more IVF or IVF-ICSI cycles. • Patients who are already taking any medication to treat endometriosis such as progestins, OCP, GnRH agonists, danazol, mirena, etc. or who have done so within the last 3 months. • Participants who do not meet World Health Organisation Group 1 or 2 eligibility requirements for Combined Oral Contraceptive use.
研究者
相似试验
已完成
不适用
Randomised controlled trial of early versus late ureteric stent removal post kidney transplantISRCTN51276329Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge (UK)350
进行中(未招募)
1 期
A single centre, randomised controlled, open label study of rituximab as induction therapy in kidney transplantation. - RituxiCam 2005EUCTR2005-001496-35-GBCambridge University Hospitals NHS Foundation Trust120
已完成
不适用
A single centre, randomised controlled, open label study of rituximab as induction therapy in kidney transplantatioISRCTN07963178Cambridge University Hospitals NHS Foundation Trust (UK)120
进行中(未招募)
1 期
An open label single center randomized controlled trial to evaluate the effect of hydroxychloroquine on viral shedding in mild COVID-19COVID-19MedDRA version: 20.0Level: HLGTClassification code 10047438Term: Viral infectious disordersSystem Organ Class: 10021881 - Infections and infestationsEUCTR2020-001417-21-BEInstitute of Tropical Medicine206
已完成
不适用
A study to measure the efficacy of tranexamic acid to reduce post partum haemorrhage volumePost-partum haemorrhagePregnancy and ChildbirthISRCTN09968140niversity Hospital Research Delegation of Lille (France)144
